Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bejon

Showing results (151-160 of 276) with videos related to

Pageof 28
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccineAmir Horowitz, Julius C R Hafalla, Elizabeth King, et al.
Malaria Journal|November 24, 2020
Building momentum for malaria vaccine research and development: key considerationsChetan E Chitnis, David Schellenberg, Johan Vekemans, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2018
Iron Status and Associated Malaria Risk Among African ChildrenJohn Muthii Muriuki, Alexander J Mentzer, Wandia Kimita, et al.
Wellcome Open Research|June 15, 2017
Micro-epidemiological structuring of <i>Plasmodium falciparum</i> parasite populations in regions with varying transmission intensities in AfricaIrene Omedo, Polycarp Mogeni, Teun Bousema, et al.
Malaria Journal|August 6, 2011
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient careJohan Vekemans, Kevin Marsh, Brian Greenwood, et al.
Wellcome Open Research|February 11, 2022
10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunityJohn W G Addy, Yaw Bediako, Francis M Ndungu, et al.
BMC Infectious Diseases|January 17, 2026
Pre-COVID-19 ex vivo cross-reactive IFN-γ cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adultsPerpetual Wanjiku, Benedict Orindi, Jedidah Mwacharo, et al.
Frontiers in Immunology|July 11, 2025
Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trialCaroline Bundi, Duncan Bellamy, Elizabeth Kibwana, et al.
Nature Communications|May 5, 2026
Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunityRodney Ogwang, Irene N Nkumama, Kennedy Mwai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 1, 2022
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populationsJames Nyagwange, Bernadette Kutima, Kennedy Mwai, et al.
Pageof 28

Showing results (151-160 of 276) with videos related to

Sort By:
Pageof 28
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccineAmir Horowitz, Julius C R Hafalla, Elizabeth King, et al.
Malaria Journal|November 24, 2020
Building momentum for malaria vaccine research and development: key considerationsChetan E Chitnis, David Schellenberg, Johan Vekemans, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2018
Iron Status and Associated Malaria Risk Among African ChildrenJohn Muthii Muriuki, Alexander J Mentzer, Wandia Kimita, et al.
Wellcome Open Research|June 15, 2017
Micro-epidemiological structuring of <i>Plasmodium falciparum</i> parasite populations in regions with varying transmission intensities in AfricaIrene Omedo, Polycarp Mogeni, Teun Bousema, et al.
Malaria Journal|August 6, 2011
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient careJohan Vekemans, Kevin Marsh, Brian Greenwood, et al.
Wellcome Open Research|February 11, 2022
10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunityJohn W G Addy, Yaw Bediako, Francis M Ndungu, et al.
BMC Infectious Diseases|January 17, 2026
Pre-COVID-19 ex vivo cross-reactive IFN-γ cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adultsPerpetual Wanjiku, Benedict Orindi, Jedidah Mwacharo, et al.
Frontiers in Immunology|July 11, 2025
Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trialCaroline Bundi, Duncan Bellamy, Elizabeth Kibwana, et al.
Nature Communications|May 5, 2026
Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunityRodney Ogwang, Irene N Nkumama, Kennedy Mwai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 1, 2022
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populationsJames Nyagwange, Bernadette Kutima, Kennedy Mwai, et al.
Pageof 28